VHL and renal carcinoma: Among the effective combinations identified from this screen, we found that a novel combination, pairing the CK2 inhibitor CX-4945 with the ATM inhibitor KU-60019, dramatically enhanced cell death in VHL-deficient renal carcinoma cells.